According to a new study that was led by researcher Dr Neil M. Bressler of Johns Hopkins University School of Medicine, steroids when injected directly into the eye can help in treating Diabetic retinopathy, which is a complication of diabetes and results in vision loss and blindness.
Proliferative diabetic retinopathy occurs when new blood vessels are formed on the optic disc or another component of the retina. The study highlighted that there is a need for further studies in identifying other treatment though laser treatments may reduce the risk of vision loss while control of blood glucose can prevent the development of retinopathy.
"Use of this intravitreal [injected into the eye] corticosteroid preparation to reduce the likelihood of progression of retinopathy is not warranted at this time because of the increased risk of glaucoma and cataract associated with intravitreal steroid use," the authors write.
"Any treatment to be used routinely to prevent proliferative diabetic retinopathy likely needs to be relatively safe because the condition already can be treated successfully and safely with panretinal photocoagulation.
“Nevertheless, further investigation with regard to the role of pharmacotherapy for reduction of the incidence of progression of retinopathy appears to be warranted," they added.
The study appeared in journal Archives of Ophthalmology, one of the JAMA/Archives journals.
Posts
No comments:
Post a Comment